Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Verseon is a technology-based pharmaceutical company developing novel therapeutics for today’s challenging diseases. The company’s proprietary drug discovery platform is the first systematic, computationally-driven solution to achieve the molecular modeling accuracy necessary for rapid and cost-effective drug discovery. Verseon plans to use its platform to establish a diversified discovery pipeline across multiple disease areas. It was founded in 2002 and is headquartered in Fremont, California.
No news articles found for Verseon.
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.